Georg Gelbenegger Selected Research

Georg Gelbenegger Research Topics

Disease

7	Thrombosis (Thrombus) 01/2023 - 01/2020
5	Hemorrhage 01/2023 - 11/2019
4	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2023 - 01/2020
4	Stroke (Strokes) 01/2021 - 11/2017
3	Hemophilia A (Haemophilia) 01/2023 - 10/2020
3	COVID-19 01/2023 - 08/2021
3	ST Elevation Myocardial Infarction 10/2022 - 02/2020
3	Myocardial Infarction 01/2021 - 11/2019
2	Disseminated Intravascular Coagulation 11/2023 - 01/2020
2	Anaphylaxis (Anaphylactic Shock) 11/2023 - 01/2022
2	Hemolysis 01/2023 - 01/2020
2	Ischemic Stroke 01/2023 - 11/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 11/2019
2	Acute Coronary Syndrome 01/2022 - 01/2021
2	Critical Illness (Critically Ill) 01/2020 - 07/2017
2	Endotoxemia 01/2019 - 07/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2024
1	Sepsis (Septicemia) 11/2023
1	Pneumonia (Pneumonitis) 10/2023
1	Infections 01/2023
1	Neutropenia 01/2023
1	AIDS-Related Complex (ARC) 10/2022
1	Bronchial Spasm 01/2022
1	Type 2 von Willebrand Disease 01/2022
1	Rhabdomyolysis 08/2021
1	Muscle Weakness 08/2021
1	Myalgia 08/2021
1	Diabetes Mellitus 01/2021
1	Proteinuria 01/2021
1	Heart Failure 01/2021
1	Thrombotic Microangiopathies 10/2020
1	Heart Arrest (Cardiac Arrest) 02/2020
1	Out-of-Hospital Cardiac Arrest 02/2020
1	Hypothermia 02/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Necrosis 07/2018
1	Inflammation (Inflammations) 07/2018
1	Dehydration (Water Stress) 11/2017
1	Type 2 Diabetes Mellitus (MODY) 11/2017

Drug/Important Bio-Agent (IBA)

4	von Willebrand FactorIBA 01/2023 - 01/2020
3	sutimlimabIBA 01/2023 - 01/2020
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2022 - 01/2021
3	TicagrelorIBA 01/2021 - 02/2020
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 11/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 07/2017
2	Dacarbazine (DIC)FDA LinkGeneric 11/2023 - 01/2020
2	AutoantibodiesIBA 01/2023 - 01/2023
2	emicizumabIBA 01/2023 - 10/2020
2	Factor VIII (Coagulation Factor VIII)IBA 01/2023 - 10/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 01/2020
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 11/2017
2	C-Reactive ProteinIBA 01/2019 - 07/2018
1	Staphylococcal enterotoxin FIBA 01/2024
1	SuperantigensIBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Bendamustine Hydrochloride FDA Link 01/2023
1	AnticoagulantsIBA 01/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	Platelet Membrane GlycoproteinsIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Ad26COVS1IBA 08/2021
1	VaccinesIBA 08/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2021
1	SymportersIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	SodiumIBA 01/2021
1	clazakizumabIBA 01/2021
1	Prasugrel Hydrochloride FDA Link 01/2021
1	Prothrombin (Factor II)IBA 10/2020
1	cangrelorIBA 02/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Complement C1s (C1 Esterase)IBA 01/2020
1	defibrotideIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 07/2018
1	ThrombomodulinIBA 07/2018
1	P-SelectinIBA 07/2018
1	vorapaxarIBA 07/2018
1	Proteinase-Activated ReceptorsIBA 07/2018
1	Sodium-Glucose Transport ProteinsIBA 11/2017
1	empagliflozinIBA 11/2017
1	Arachidonic Acid (Vitamin F)IBA 07/2017

Therapy/Procedure

7	Therapeutics 10/2023 - 07/2017
3	Stents 04/2022 - 02/2020
2	Subcutaneous Injections 01/2023 - 08/2021
1	Thrombectomy 01/2023
1	Extracorporeal Membrane Oxygenation 01/2022
1	Stem Cell Transplantation 01/2019
1	Nursing Care 11/2017